Adjusted net asset value (SEK bn) March 31, 2023
Brian LaDuke, currently, President of Sarnova’s Cardiac Response division, has been appointed as the next CEO of Sarnova
The Board of Atlas Antibodies and Nille Klaebel have together agreed that Nille will leave her position as the CEO of Atlas Antibodies Group.
Our portfolio is organized in three business areas: Listed Companies, Patricia Industries and Investments in EQT.